Genomics and Cancer Drug Resistance

E-ISSN： 1873-4316|13|5|651-673

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.5, 2012-04, pp. : 651-673

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-drug resistance and cancer

By Atalay Can

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite

Innovative cancer drug targets: genomics, transcriptomics and clinomics

By Clarke Paul A Workman Paul

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 911-915

Informa Healthcare

Access to resources Recommend Favorite

Overcoming drug resistance in pancreatic cancer

By Long Jiang Zhang Yuqing Yu Xianjun Yang Jingxuan LeBrun Drake G Chen Changyi Yao Qizhi Li Min

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 817-828

Informa Healthcare

Access to resources Recommend Favorite

The Role of Emerging Genomics and Proteomics Technologies in Cancer Drug Target Discovery

Current Cancer Drug Targets, Vol. 4, Iss. 2, 2004-03 ,pp. : 111-124

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Malaria Genomics, Drug Targets, and Drug Resistance (Guest Editor: Xin-zhuan Su)]

Current Drug Targets - Infectious Disorders, Vol. 4, Iss. 1, 2004-03 ,pp. : i-ii

Bentham Science Publishers

Access to resources Recommend Favorite